Find Therapeutics raised $8.1 million in a convertible note financing led by Investissement Québec to advance FTX-101 into Phase 1 clinical studies.
Find Therapeutics raised $8.1 million in a convertible note financing led by Investissement Québec to advance FTX-101 into Phase 1 clinical studies.
09/16/24, 11:27 AM
Location
montrealMoney raised
$8.1 million
Industry
biopharma
therapeutics
biotechnology
health care
Investors
Ad Mare Bio Innovations, Cti Life Sciences Fund, Investissement Québec
Find Therapeutics Inc. announced the closing of a $8.1 million convertible note financing with Investissement Québec and current investors CTI Life Sciences Fund and adMare BioInnovations. The proceeds will be used to advance FTX-101 into Phase 1 clinical studies.
Company Info
Location
montreal, quebec, canada
Additional Info
Find Therapeutics is a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases. The company was launched in 2020 and is dedicated to the development of next generation therapies to treat inflammatory autoimmune diseases.